Global Pentavalent Vaccine Market- Industry Analysis, Growth, Segmentation and Forecast-2020-2026

The Global Pentavalent Vaccine Market was valued $xx Mn in 2019 and is expected to reach $xx Mn by 2026, at a CAGR of xx%.

Market Introduction and Overview

The pentavalent vaccine is a fully liquid vaccine. It combines five antigens for protection against potentially life-threatening childhood diseases: diphtheria, tetanus, pertussis, hepatitis B, and illnesses caused by Haemophilus influenzae type B. The fully liquid vaccine is currently a component of national immunization schedules in at least 65 countries eligible to receive vaccines through the GAVI Alliance. Corynebacterium diphteriae is a bacterium which can cause myocarditis (inflammation of the heart muscle), inflammation of nerves and kidney problems. It is transmitted by contact, by contaminated objects or through the air. According to World Health Organization (WHO) data, incidence of diphtheria is on the rise: countries reported more than 7,000 cases in 2016, and almost 17,000 in 2018. Death occurs in 5% to 10% of those infected, mainly in children under 5 years of age. The increasing prevalence of Diphtheria, Tetanus, Pertussis and Hepatitis B is growing the market of pentavalent vaccine rapidly. Pentavalent vaccine brings cost savings in terms of equipment, delivery and disposal programmes. Investments of emerging manufacturers in the market is considerable and includes sourcing of component vaccines, technology transfers, clinical and analytical development, registration and prequalification activities as well as building manufacturing capacity to meet increasing demand.

Drivers for the Pentavalent Vaccine Market

• Market interventions including technical support by the WHO to manufacturers, technical assistance to several manufacturers facilitated through PATH and funded by the BMGF are intended to increase production efficiencies and improve production economics, primarily for the older manufacturing methods for DTwP. • In 2019, Panacea Biotech bagged orders worth USD 24.32 million (over Rs 170 crore) from UN agencies, including UNICEF, for the supply of pentavalent vaccine. Panacea Biotech has received awards worth USD 24.32 million from UN agencies (Unicef and PAHO) for supply of its Easyfive-TT, a fully liquid WHO prequalified wP-based Pentavalent vaccine (DTwPHepB-Hib). • UNICEF anticipates total aggregate pentavalent vaccine forecast demand up to 2019 to reach 449 million doses, averaging 150 million doses a year. • Entry of new vaccine developers in the market. • Robust Research and Development factors.

Segment Analysis

Pentavalent (DTP-Hep B-Hib) vaccines are available in both the liquid and freeze-dried forms. However in the freeze-dried form combined DTP-Hep B is available in liquid form and Hib component as freeze dried and therefore the latter should be reconstituted (mixed) before use. It has been decided to use liquid form Pentavalent (DTP-HepB-Hib)vaccine in the national EPI programme considering the convenience of using liquid form of Pentavalent (DTP-HepB-Hib)vaccine at busy immunization clinics,. At present, only single dose liquid form Pentavalent (DTP-HepB-Hib) vaccine is available. The Hib vaccines in various formulation are licensed in India for almost a decade and widely used in the private sector. Longer shelf life, precise composition and high effectiveness of the powdered form are expanding the segment growth. The pharmacy retail market in India has witnessed significant growth over the past few years, owing to favourable demographic factors and an epidemiological transition. Rise in patient care initiatives by retail pharmacies. Patients prefer purchasing drugs from retail pharmacies rather than hospitals and therefore, the segment is expected to retain its lead throughout the forecast period. Global Pentavalent Vaccine Market To know about the Research Methodology :- Request Free Sample Report

Regional Insights

Global Pentavalent Vaccine Market1 North America accounted for the largest market share of xx% in 2020 and is expected to grow a CAGR of xx% in the forecast period. Growth in insurance coverage, presence of centres and institutes engaged in R&D and government funding are up surging the North American market. Well-established healthcare infrastructure, ease of availability and increasing immunization program are also key drivers affecting the market growth. Investments by key players in this field has boosted the market growth. Europe is also expected to drive the market and the factors responsible for growth are the growing acceptance of emerging advanced technologies, rising incidence of Hep-B and tetanus. Asia Pacific is also expected to witness significant growth during the forecast period due to rising health care expenditures. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand. Compulsory and free immunization programs by governments are also driving the market in the region. Global Pentavalent Vaccine Market2

Scope of the Report: Inquire before Buying

Global Pentavalent Vaccine Market3

By Region

• North America • Europe • South America • MEA • Asia Pacific

Key Players Operating in the Global Pentavalent Vaccine Market

• Serum Institute of India • Panacea Drugs Pvt. Ltd • Shantha Biotechnics • Biological E. Ltd. • Novartis AG The report also helps in understanding Global Pentavalent Vaccine Market dynamics, structure by analysing the market segments and project the Global Pentavalent Vaccine Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Pentavalent Vaccine Market make the report investor’s guide.
Global Pentavalent Vaccine Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: PENTAVALENT VACCINE Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global PENTAVALENT VACCINE Market Analysis and Forecast 6.1. PENTAVALENT VACCINE Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global PENTAVALENT VACCINE Market Analysis and Forecast, By Formulation Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. PENTAVALENT VACCINE Market Value Share Analysis, By Formulation Type 7.4. PENTAVALENT VACCINE Market Size (US$ Mn) Forecast, By Formulation Type 7.5. PENTAVALENT VACCINE Market Analysis, By Formulation Type 7.6. PENTAVALENT VACCINE Market Attractiveness Analysis, By Formulation Type 8. Global PENTAVALENT VACCINE Market Analysis and Forecast, By Distribution Channel 8.1. Introduction and Definition 8.2. Key Findings 8.3. PENTAVALENT VACCINE Market Value Share Analysis, By Distribution Channel 8.4. PENTAVALENT VACCINE Market Size (US$ Mn) Forecast, By Distribution Channel 8.5. PENTAVALENT VACCINE Market Analysis, By Distribution Channel 8.6. PENTAVALENT VACCINE Market Attractiveness Analysis, By Distribution Channel 9. Global PENTAVALENT VACCINE Market Analysis, By Region 9.1. PENTAVALENT VACCINE Market Value Share Analysis, By Region 9.2. PENTAVALENT VACCINE Market Size (US$ Mn) Forecast, By Region 9.3. PENTAVALENT VACCINE Market Attractiveness Analysis, By Region 10. North America PENTAVALENT VACCINE Market Analysis 10.1. Key Findings 10.2. North America PENTAVALENT VACCINE Market Overview 10.3. North America PENTAVALENT VACCINE Market Value Share Analysis, By Formulation Type 10.4. North America PENTAVALENT VACCINE Market Forecast, By Formulation Type 10.4.1. Lyophilized 10.4.2. Liquid 10.5. North America PENTAVALENT VACCINE Market Value Share Analysis, By Distribution Channel 10.6. North America PENTAVALENT VACCINE Market Forecast, By Distribution Channel 10.6.1. Retail Pharmacy 10.6.2. Hospital Pharmacy 10.6.3. E-commerce 10.7. North America PENTAVALENT VACCINE Market Value Share Analysis, By Country 10.8. North America PENTAVALENT VACCINE Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America PENTAVALENT VACCINE Market Analysis, By Country 10.10. U.S. PENTAVALENT VACCINE Market Forecast, By Formulation Type 10.10.1. Lyophilized 10.10.2. Liquid 10.11. U.S. PENTAVALENT VACCINE Market Forecast, By Distribution Channel 10.11.1. Retail Pharmacy 10.11.2. Hospital Pharmacy 10.11.3. E-commerce 10.12. Canada PENTAVALENT VACCINE Market Forecast, By Formulation Type 10.12.1. Lyophilized 10.12.2. Liquid 10.13. Canada PENTAVALENT VACCINE Market Forecast, By Distribution Channel 10.13.1. Retail Pharmacy 10.13.2. Hospital Pharmacy 10.13.3. E-commerce 10.14. Mexico PENTAVALENT VACCINE Market Forecast, By Formulation Type 10.14.1. Lyophilized 10.14.2. Liquid 10.15. Mexico PENTAVALENT VACCINE Market Forecast, By Distribution Channel 10.15.1. Retail Pharmacy 10.15.2. Hospital Pharmacy 10.15.3. E-commerce 10.16. North America PENTAVALENT VACCINE Market Attractiveness Analysis 10.16.1. By Formulation Type 10.16.2. By Distribution Channel 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe PENTAVALENT VACCINE Market Analysis 11.1. Key Findings 11.2. Europe PENTAVALENT VACCINE Market Overview 11.3. Europe PENTAVALENT VACCINE Market Value Share Analysis, By Formulation Type 11.4. Europe PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.4.1. Lyophilized 11.4.2. Liquid 11.5. Europe PENTAVALENT VACCINE Market Value Share Analysis, By Distribution Channel 11.6. Europe PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.6.1. Retail Pharmacy 11.6.2. Hospital Pharmacy 11.6.3. E-commerce 11.7. Europe PENTAVALENT VACCINE Market Value Share Analysis, By Country 11.8. Europe PENTAVALENT VACCINE Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.9.1. Lyophilized 11.9.2. Liquid 11.10. Germany PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.10.1. Retail Pharmacy 11.10.2. Hospital Pharmacy 11.10.3. E-commerce 11.11. U.K. PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.11.1. Lyophilized 11.11.2. Liquid 11.12. U.K. PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.12.1. Retail Pharmacy 11.12.2. Hospital Pharmacy 11.12.3. E-commerce 11.13. France PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.13.1. Lyophilized 11.13.2. Liquid 11.14. France PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.14.1. Retail Pharmacy 11.14.2. Hospital Pharmacy 11.14.3. E-commerce 11.15. Italy PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.15.1. Lyophilized 11.15.2. Liquid 11.16. Italy PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.16.1. Retail Pharmacy 11.16.2. Hospital Pharmacy 11.16.3. E-commerce 11.17. Spain PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.17.1. Lyophilized 11.17.2. Liquid 11.18. Spain PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.18.1. Retail Pharmacy 11.18.2. Hospital Pharmacy 11.18.3. E-commerce 11.19. Sweden PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.19.1. Lyophilized 11.19.2. Liquid 11.20. Sweden PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.20.1. Retail Pharmacy 11.20.2. Hospital Pharmacy 11.20.3. E-commerce 11.21. CIS countries PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.21.1. Lyophilized 11.21.2. Liquid 11.22. CIS countries PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.22.1. Retail Pharmacy 11.22.2. Hospital Pharmacy 11.22.3. E-commerce 11.23. Rest of Europe PENTAVALENT VACCINE Market Forecast, By Formulation Type 11.23.1. Lyophilized 11.23.2. Liquid 11.24. Rest of Europe PENTAVALENT VACCINE Market Forecast, By Distribution Channel 11.24.1. Retail Pharmacy 11.24.2. Hospital Pharmacy 11.24.3. E-commerce 11.25. Europe PENTAVALENT VACCINE Market Attractiveness Analysis 11.25.1. By Distribution Channel 11.25.2. By Formulation Type 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific PENTAVALENT VACCINE Market Analysis 12.1. Key Findings 12.2. Asia Pacific PENTAVALENT VACCINE Market Overview 12.3. Asia Pacific PENTAVALENT VACCINE Market Value Share Analysis, By Formulation Type 12.4. Asia Pacific PENTAVALENT VACCINE Market Forecast, By Formulation Type 12.4.1. Lyophilized 12.4.2. Liquid 12.5. Asia Pacific PENTAVALENT VACCINE Market Value Share Analysis, By Distribution Channel 12.6. Asia Pacific PENTAVALENT VACCINE Market Forecast, By Distribution Channel 12.6.1. Retail Pharmacy 12.6.2. Hospital Pharmacy 12.6.3. E-commerce 12.7. Asia Pacific PENTAVALENT VACCINE Market Value Share Analysis, By Country 12.8. Asia Pacific PENTAVALENT VACCINE Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific PENTAVALENT VACCINE Market Analysis, By Country 12.10. China PENTAVALENT VACCINE Market Forecast, By Formulation Type 12.10.1. Lyophilized 12.10.2. Liquid 12.11. China PENTAVALENT VACCINE Market Forecast, By Distribution Channel 12.11.1. Retail Pharmacy 12.11.2. Hospital Pharmacy 12.11.3. E-commerce 12.12. India PENTAVALENT VACCINE Market Forecast, By Formulation Type 12.12.1. Lyophilized 12.12.2. Liquid 12.13. India PENTAVALENT VACCINE Market Forecast, By Distribution Channel 12.13.1. Retail Pharmacy 12.13.2. Hospital Pharmacy 12.13.3. E-commerce 12.14. Japan PENTAVALENT VACCINE Market Forecast, By Formulation Type 12.14.1. Lyophilized 12.14.2. Liquid 12.15. Japan PENTAVALENT VACCINE Market Forecast, By Distribution Channel 12.15.1. Retail Pharmacy 12.15.2. Hospital Pharmacy 12.15.3. E-commerce 12.16. South Korea PENTAVALENT VACCINE Market Forecast, By Formulation Type 12.16.1. Lyophilized 12.16.2. Liquid 12.17. South Korea PENTAVALENT VACCINE Market Forecast, By Distribution Channel 12.17.1. Retail Pharmacy 12.17.2. Hospital Pharmacy 12.17.3. E-commerce 12.18. Australia PENTAVALENT VACCINE Market Forecast, By Formulation Type 12.18.1. Lyophilized 12.18.2. Liquid 12.19. Australia PENTAVALENT VACCINE Market Forecast, By Distribution Channel 12.19.1. Retail Pharmacy 12.19.2. Hospital Pharmacy 12.19.3. E-commerce 12.20. ASEAN PENTAVALENT VACCINE Market Forecast, By Formulation Type 12.20.1. Lyophilized 12.20.2. Liquid 12.21. ASEAN PENTAVALENT VACCINE Market Forecast, By Distribution Channel 12.21.1. Retail Pharmacy 12.21.2. Hospital Pharmacy 12.21.3. E-commerce 12.22. Rest of Asia Pacific PENTAVALENT VACCINE Market Forecast, By Formulation Type 12.22.1. Lyophilized 12.22.2. Liquid 12.23. Rest of Asia Pacific PENTAVALENT VACCINE Market Forecast, By Distribution Channel 12.23.1. Retail Pharmacy 12.23.2. Hospital Pharmacy 12.23.3. E-commerce 12.24. Asia Pacific PENTAVALENT VACCINE Market Attractiveness Analysis 12.24.1. By Formulation Type 12.24.2. By Distribution Channel 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa PENTAVALENT VACCINE Market Analysis 13.1. Key Findings 13.2. Middle East & Africa PENTAVALENT VACCINE Market Overview 13.3. Middle East & Africa PENTAVALENT VACCINE Market Value Share Analysis, By Formulation Type 13.4. Middle East & Africa PENTAVALENT VACCINE Market Forecast, By Formulation Type 13.4.1. Lyophilized 13.4.2. Liquid 13.5. Middle East & Africa PENTAVALENT VACCINE Market Value Share Analysis, By Distribution Channel 13.6. Middle East & Africa PENTAVALENT VACCINE Market Forecast, By Distribution Channel 13.6.1. Retail Pharmacy 13.6.2. Hospital Pharmacy 13.6.3. E-commerce 13.7. Middle East & Africa PENTAVALENT VACCINE Market Value Share Analysis, By Country 13.8. Middle East & Africa PENTAVALENT VACCINE Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa PENTAVALENT VACCINE Market Analysis, By Country 13.10. GCC Countries PENTAVALENT VACCINE Market Forecast, By Formulation Type 13.10.1. Lyophilized 13.10.2. Liquid 13.11. GCC Countries PENTAVALENT VACCINE Market Forecast, By Distribution Channel 13.11.1. Retail Pharmacy 13.11.2. Hospital Pharmacy 13.11.3. E-commerce 13.12. South Africa PENTAVALENT VACCINE Market Forecast, By Formulation Type 13.12.1. Lyophilized 13.12.2. Liquid 13.13. South Africa PENTAVALENT VACCINE Market Forecast, By Distribution Channel 13.13.1. Retail Pharmacy 13.13.2. Hospital Pharmacy 13.13.3. E-commerce 13.14. Nigeria PENTAVALENT VACCINE Market Forecast, By Formulation Type 13.14.1. Lyophilized 13.14.2. Liquid 13.15. Nigeria PENTAVALENT VACCINE Market Forecast, By Distribution Channel 13.15.1. Retail Pharmacy 13.15.2. Hospital Pharmacy 13.15.3. E-commerce 13.16. Egypt PENTAVALENT VACCINE Market Forecast, By Formulation Type 13.16.1. Lyophilized 13.16.2. Liquid 13.17. Egypt PENTAVALENT VACCINE Market Forecast, By Distribution Channel 13.17.1. Retail Pharmacy 13.17.2. Hospital Pharmacy 13.17.3. E-commerce 13.18. Rest of Middle East & Africa PENTAVALENT VACCINE Market Forecast, By Formulation Type 13.18.1. Lyophilized 13.18.2. Liquid 13.19. Rest of Middle East & Africa PENTAVALENT VACCINE Market Forecast, By Distribution Channel 13.19.1. Retail Pharmacy 13.19.2. Hospital Pharmacy 13.19.3. E-commerce 13.20. Middle East & Africa PENTAVALENT VACCINE Market Attractiveness Analysis 13.20.1. By Formulation Type 13.20.2. By Distribution Channel 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America PENTAVALENT VACCINE Market Analysis 14.1. Key Findings 14.2. South America PENTAVALENT VACCINE Market Overview 14.3. South America PENTAVALENT VACCINE Market Value Share Analysis, By Formulation Type 14.4. South America PENTAVALENT VACCINE Market Forecast, By Formulation Type 14.4.1. Lyophilized 14.4.2. Liquid 14.5. South America PENTAVALENT VACCINE Market Value Share Analysis, By Distribution Channel 14.6. South America PENTAVALENT VACCINE Market Forecast, By Distribution Channel 14.6.1. Retail Pharmacy 14.6.2. Hospital Pharmacy 14.6.3. E-commerce 14.7. South America PENTAVALENT VACCINE Market Value Share Analysis, By Country 14.8. South America PENTAVALENT VACCINE Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America PENTAVALENT VACCINE Market Analysis, By Country 14.10. Brazil PENTAVALENT VACCINE Market Forecast, By Formulation Type 14.10.1. Lyophilized 14.10.2. Liquid 14.11. Brazil PENTAVALENT VACCINE Market Forecast, By Distribution Channel 14.11.1. Retail Pharmacy 14.11.2. Hospital Pharmacy 14.11.3. E-commerce 14.12. Colombia PENTAVALENT VACCINE Market Forecast, By Formulation Type 14.12.1. Lyophilized 14.12.2. Liquid 14.13. Colombia PENTAVALENT VACCINE Market Forecast, By Distribution Channel 14.13.1. Retail Pharmacy 14.13.2. Hospital Pharmacy 14.13.3. E-commerce 14.14. Argentina PENTAVALENT VACCINE Market Forecast, By Formulation Type 14.14.1. Lyophilized 14.14.2. Liquid 14.15. Argentina PENTAVALENT VACCINE Market Forecast, By Distribution Channel 14.15.1. Retail Pharmacy 14.15.2. Hospital Pharmacy 14.15.3. E-commerce 14.16. Rest of South America PENTAVALENT VACCINE Market Forecast, By Formulation Type 14.16.1. Lyophilized 14.16.2. Liquid 14.17. Rest of South America PENTAVALENT VACCINE Market Forecast, By Distribution Channel 14.17.1. Retail Pharmacy 14.17.2. Hospital Pharmacy 14.17.3. E-commerce 14.18. South America PENTAVALENT VACCINE Market Attractiveness Analysis 14.18.1. By Formulation Type 14.18.2. By Distribution Channel 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, Distribution Channel, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and Distribution Channel 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Serum Institute of India 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Panacea Drugs Pvt. Ltd 15.3.3. Shantha Biotechnics 15.3.4. Biological E. Ltd. 15.3.5. Novartis AG

About This Report

Report ID85865
Category Healthcare
Published DateMarch 2021
Updated DateOct 2021
Contact Us